nuclear phase-out policy
Scope
Date
~
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets OK partial approval for phase 3 of biosimilar in Europe
South Korean biopharmaceutical company Celltrion Inc. announced on Tuesday that it has received approval from the European Medicines Agency (EMA) fo...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Central bank
BOK head says Korea inflation to dip below mid-2% in H2 2024
South Korea’s central bank chief expected consumer inflation to fall below the mid-2% level in the second half of 2024, adding to predictions ...
Aug 22, 2023 (Gmt+09:00)
-
Energy
Daewoo E&C, KAERI to team up for nuclear tech research
South Korea's Daewoo Engineering & Construction Co. (Daewoo E&C) announced on Friday that it signed a research collaboration memorandum of u...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Construction & Planning
Heerim wins supervision contract for Vietnam's Long Thanh Airport
South Korea's Heerim Architects & Planners announced on Monday that it has signed a construction-phase supervision and advisory contract for the...
Aug 07, 2023 (Gmt+09:00)
-
Energy
Westinghouse, KHNP seek licensing dispute arbitration
Korea Hydro & Nuclear Power Co. (KHNP) and Westinghouse Electric Corp. have taken their almost one-year dispute over South Korea’s nuclear...
Aug 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Energy
Daewoo E&C, SK Ecoplant to cooperate in nuclear power
South Korea’s Daewoo Engineering & Construction Co. (Daewoo E&C) and SK Ecoplant Co. will jointly take on the domestic and overseas ma...
Jul 27, 2023 (Gmt+09:00)
-
Energy
KHNP develops world's first accident monitoring system for nuclear reactors
Korea Hydro & Nuclear Power (KHNP) announced on Wednesday that it has successfully developed the Technical Specification Operator Support System...
Jul 19, 2023 (Gmt+09:00)
-
Central bank
BOK warns of household lending risk on growth, inequality
South Korea’s central bank warned that household lending in the country has leaped to the world’s third highest and could hurt long-term...
Jul 17, 2023 (Gmt+09:00)
-
Business & Politics
Korea revives nuclear power for its 2024-2038 energy plan
South Korea is slated to bring forward action steps on its power supply plan for the 2024-2038 period, with a possibility to review building more nu...
Jul 11, 2023 (Gmt+09:00)
-
Electric vehicles
Korea tops US eco-friendly car import rankings despite IRA disadvantage
South Korea retained its top spot in exports of eco-friendly vehicles including electric cars to the US in the first quarter despite challenges pose...
Jul 10, 2023 (Gmt+09:00)
-
Content platforms
S.Korea’s contents export size surpasses home appliances, textiles
South Korea's contents export size recorded $13.3 billion last year, surpassing the export values of home appliances ($8 billion) and textile produc...
Jul 06, 2023 (Gmt+09:00)
-
North Korea
US to send Its biggest sub to Korean Peninsula in message to North and South
SEOUL—The U.S. plans to send its largest nuclear-armed submarine to South Korea for the first time in four decades, in an effort to deter Nort...
Jun 28, 2023 (Gmt+09:00)
-
Energy
Korea’s KHNP wins project for tritium removal plant in Romania
State-backed Korea Hydro & Nuclear Power Co. (KHNP) has won a €200 million order to build a tritium removal facility (TRF) at a nuclear pow...
Jun 27, 2023 (Gmt+09:00)
-
North Korea
How North Korea’s Hacker Army Stole $3 Billion in Crypto, Funding Nuclear Program
Last year an engineer working for the blockchain gaming company Sky Mavis thought he was on the cusp of a new job that would pay more money.A recrui...
Jun 26, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Korean startups
Seoul to build world's largest startup campus by 2030
The Seoul Metropolitan Government will establish the world’s largest startup campus in the capital city of South Korea by 2030, benchmarking S...
Jun 21, 2023 (Gmt+09:00)
-
Foreign exchange
Yen breaches key level vs Korean won to hit 8-year low
The Japanese yen on Monday extended losses against the South Korean won to touch an eight-year low, briefly breaching a psychological support line a...
Jun 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm's Efinopegdutide gets Fast Track Designation from FDA
Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...
Jun 13, 2023 (Gmt+09:00)
-
Business & Politics
US emerges key to Korea’s nuclear power plants exports to Saudi Arabia
Saudi Arabia, which is seeking to build two 1.4 gigawatts (GW) nuclear power plants, is demanding that the US allow uranium enrichment, according to...
Jun 09, 2023 (Gmt+09:00)
-
Energy
Challenges, opportunities for Asia’s energy transition: GIG
Global investors injected more than $1 trillion into energy transition for the first time last year. South Korea poured in some $19 billion, becomin...
Jun 07, 2023 (Gmt+09:00)
-
Energy
S.Korea to design proven type reactor of nuclear fusion power
South Korean government has initiated the design phase for a nuclear fusion power proven type reactor, taking a significant step toward harnessing n...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)